Survey reveals almost three quarters of travellers would be happy to fly long haul with no frills

A study conducted by leading global travel search site Skyscanner reveals 74% of travellers would be willing to sacrifice the extras received with traditional airlines in order to travel long haul (more than four hours) with a budget carrier.

The survey of more than 1800 travellers found that of those willing to fly long haul low cost, 48% would forfeit their personal space and endure limited legroom for anything up to nine hours in order to reach their destination, while nearly one in three (30%) would be willing to sit out a bum breaking 10-hour flight (equivalent of a flight from Singapore to London). However 22% would only endure the basic levels of comfort offered by budget airlines for a relatively modest flying time of four to six hours.

The study also questioned travellers on the “extras” they would most need in order to persuade them to fly long haul low cost.

With most low cost airlines offering an average seat pitch of just 29 inches, this survey reveals that size really does matter with more than a third (35%) of travellers requiring an extra two inches of legroom in order to travel long haul with a no-frills airlines, and would prioritise legroom over in-flight entertainment (14%) or even in flight food and refreshments (9%) for the duration of the long haul journey. 18% wanted free hold baggage included.

Sam Baldwin, Travel Editor at Skyscanner said; “The results of this survey show there is a definite demand for low cost airlines to operate long haul routes – it appears people are more than happy to surrender some level of comfort in order to satisfy their taste for travel, as long as the price is right. In recent years, low cost airlines have started to introduce more mid haul routes, so it is not unfeasible that long haul routes could be next to be added.”

About Skyscanner

Skyscanner is a leading travel search site providing instant online comparisons for millions of flights on over a thousand airlines, as well as hotels and car hire.

Source: Skyscanner

International Game Technology (NYSE: IGT) will showcase a portfolio of games tailored to the specific demands of Asian markets during G2E Asia 2012 at The Venetian Macao in Macau, May 22 – 24.

“IGT is proud to introduce our newest Asian market-attuned games and industry-leading systems products that are designed to deliver performance and profitably for our customers,” said Craig Churchill, IGT senior vice president International. “Our innovative line-up at G2E Asia highlights our continued commitment to customers in these rapidly expanding markets.”

More than half of IGT games at this year’s show are designed to focus on local markets with the themes, dual languages (Chinese and English), and math models that Asian casinos and players are seeking. The array of games contains legendary Chinese themes such as West Journey Treasure Hunt(TM) and Golden Three Kingdom(TM), as well as appealing titles such as Four Great Chinese Beauties(R), Big Dragon Lounge(TM) and Pearl Dragon(TM).

The Company will spotlight the industry’s first community play five-reel slot, Fast-Hit Progressives(TM), which is available in Chinese. Also showcased at G2E Asia are blockbusters The Dark Knight and Ghostbusters(TM) on the eye-catching Center Stage(TM). After installing Center Stage(TM), Operators can refresh content with the latest games featuring big, bold titles. These entertaining titles join a full lineup of IGT’s games including MegaJackpots(R) Premium Products favorites, Sex and the City Fabulous(TM) MultiPLAY and Elvis The King(R) Multi-Level Progressives.
Industry-leading IGT cabinet designs will include the exclusive G23 and the Universal Slant models, which allow for personalised playing experiences and flexibility for Operators.

IGT’s Systems products at G2E Asia 2012 include leading server-based gaming tools offering dynamic ways to communicate with players, unmatched flexibility and connectivity, and the critical tools needed to manage the floor, players, promotions and operations. Highlighted products include IGT’s sbX(TM) server-based experience, IGT Advantage(R), IGT Casinolink(TM). With more than 50 installs in 11 countries, G2E Asia attendees will experience the power a server-based floor can create.

Visit IGT at stand No. 700 at G2E Asia to see how IGT’s global strength and locally focused solutions help customers succeed in Asian markets. For more information, visit www.igt.com.

About IGT
International Game Technology (NYSE: IGT) is a global leader in the design, development and manufacture of gaming machines and systems products, as well as online and mobile gaming solutions for regulated markets. More information about IGT is available at www.IGT.com or follow IGT on Twitter at @IGTNews or Facebook at www.facebook.com/IGT.

THE DARK KNIGHT and all related characters and elements are trademarks of and (C) DC Comics.

(s12)

Ghostbusters: TM & (C) 2012 Columbia Pictures Industries Inc. All Rights Reserved.

Official HBO Licensed Product. (C) 2012 Home Box Office, Inc. All Rights Reserved. HBO and related trademarks are the property of Home Box Office, Inc.

(C) EPE, Reg. U.S. Pat & TM O_.

CONTACT: Shelle Murach of IGT Public Relations, +1-775-448-0221, Shelle.Murach@IGT.com

Study Results Will be Used to Support PMA Application for the RePneu LVRC System

PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has received FDA approval to commence a 30-site pivotal clinical trial to support a PMA application for the RePneu LVRC System.

(Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO)

The RePneu LVRC System is a minimally invasive device intended to improve lung function in emphysema patients by bronchoscopically implanting Nitinol coils into the lungs to compress diseased tissue (lung volume reduction), restore elastic recoil, and adjust lung compliance. This treatment offers a minimally invasive alternative to lung volume reduction surgery to a broad range of emphysema patients.

The RePneu LVRC has already undergone extensive clinical studies in Europe, with impressive results in over 250 treatments. The majority of subjects who underwent RePneu LVRC treatment in PneumRx’s European clinical trials experienced significant improvement in lung function, exercise capacity and quality of life at both 6 months and one year after treatment, with minimal risk. 74% of all clinical subjects maintained a clinically significant improvement in exercise capacity at 12 months post-treatment and 96% experienced significant improvement in quality of life.

Specifically, RePneu LVRC subjects experienced a mean improvement in Six-Minute Walk Test of 62 meters; a 12% increase in FEV1, a 10% decrease in Residual Volume and a decrease of 12 points in the St. George’s Respiratory Questionnaire, at 12 months. The European clinical trial results were used to support PneumRx’s CE Mark, and the RePneu LVRC System has been commercially available in Europe since 2010.

The RePneu LVRC has proven effective in patients with both heterogeneous and homogeneous disease, in both the upper and lower lobes, and it works independently of collateral ventilation. The safety profile of the RePneu LVRC System is comparable to that of a simple bronchoscopy procedure, with the majority of adverse results occurring, and resolving, within 30 days of treatment. Patients generally return home from the hospital the day after the treatment.

“We are thrilled to have IDE approval for the RePneu LVRC and are eager to bring this exciting technology to the United States,” said Erin McGurk, PneumRx’s President and CEO. “It has been so gratifying to see the benefits the RePneu LVRC treatment has brought to emphysema patients in Europe and we are especially pleased to be able to bring these benefits to a greater number of patients suffering from this debilitating disease here in the United States. We plan to treat over 300 subjects in our pivotal trial, and expect to start enrolling clinical subjects in the coming months. We look forward to submitting the pivotal trial results in support of a PMA application to sell the RePneu LVRC System in the United States.”

“The entire PneumRx team, in partnership with our accomplished team of Physician Advisors, has worked tirelessly to support the RePneu LVRC IDE application and design an appropriate clinical trial,” stated Kara Andersen Reiter, Vice President of Regulatory Affairs at PneumRx. “We are grateful to the FDA team who reviewed our IDE application and worked with us to bring our submission over the finish line.”

About PneumRx, Inc.

PneumRx, Inc. is a rapidly growing medical device company focused on the development and commercialization of innovative products to treat emphysema using minimally-invasive techniques. It is a privately held company located in Mountain View, California.

Website
www.pneumrx.com

CONTACT: PneumRx, Inc., PneumRx, GmbH, Erin McGurk, President & CEO, +1-650-625-8910, ext. 110, Erin@pneumrx.com

— OAG processes up to 50,000 airline schedule-change messages per day

OAG, the global leader in aviation intelligence, and Amadeus, a leading travel technology partner and transaction processor for the global travel and tourism industry, today announce a new enhancement to provide best-in-class airline schedule information. Under the agreement, OAG now provides to Amadeus a daily transmission of schedule data files. OAG’s data is used globally by Amadeus-served travel management companies, travel websites, and agencies.

(Logo: http://photos.prnewswire.com/prnh/20110908/NY64578LOGO )

“Amadeus is the first global distribution system to use a daily OAG schedule feed,” said John Grant, EVP Networks of UBM Aviation, parent company of OAG. “This enables travel agents and their customers to access more accurate information when they’re looking to book a flight – a major competitive advantage for any global distribution system.”

The OAG database contains schedules for over 1,000 airlines and over 4,000 airports. The database tracks over 28 million departures a year ahead. This data is updated continuously, and OAG processes up to 50,000 airline schedule-change messages per day.

“Airlines change their flight schedules to enhance margins, meet market demand, and seize competitive advantage and it is key that this information is made available quickly to travel agencies,” said David Doctor, Director Distribution Marketing, Amadeus. “With this new agreement, we can ensure that, for airlines which file their information in OAG, schedule changes are processed and new flights proposed for sale, immediately on the day.”

Approximately one third of the flight schedules in the Amadeus system are based on OAG?s data. Airlines can also update their schedules directly in the Amadeus system.

Notes to the editors

About OAG
OAG, a UBM Aviation brand, is the trusted source for aviation information and analytical services. Our leading aviation databases unrivalled in their scale, accuracy and comprehensiveness are integral to the worlds’ aviation industry operations. For more information, visit www.oag.com.

About UBM Aviation
UBM Aviation, a UBM plc company, is the pioneer of innovative market leading aviation solutions. Our instantly recognisable brands provide the data, analysis, events, media and consultancy services that drive route development and financial growth for our customers’ businesses. For more information, visit www.ubmaviation.com.

About Amadeus
Amadeus is a leading transaction processor and provider of advanced technology solutions for the global travel and tourism industry.

Customer groups include travel providers (e.g. airlines, hotels, rail, ferries, etc.), travel sellers (travel agencies and websites), and travel buyers (corporations and individual travellers).

The group operates a transaction-based business model and processed more than 947 million billable travel transactions in 2011.

Amadeus has central sites in Madrid (corporate headquarters), Nice (development) and Erding (operations – data processing centre) and regional offices in Miami, Buenos Aires, Bangkok and Dubai. At a market level, Amadeus maintains customer operations through 73 local Amadeus Commercial Organisations covering 195 countries.

Amadeus is listed on the Madrid, Barcelona, Bilbao and Valencia stock exchanges and trades under the symbol “AMS.MC”. For the year ended December 31, 2011 the company reported like-for-like revenues of euro 2,712 million and EBITDA of euro 1,039 million. The Amadeus group employs around 10,000 people worldwide, with 123 nationalities represented at the central offices.

To find out more about Amadeus please visit www.amadeus.com

To visit the Amadeus Investor Relations centre please www.investors.amadeus.com

CONTACT: For OAG, Andrew Sibley, Corporate Communications, UBM Aviation, pressoffice@ubmaviation.com or Amadeus, Corporate Communication, +34 91 582 0160 or fax, +34 91 582 0188, mediarelations@amadeus.com

– Bacardi builds on long-standing foundation of corporate and social responsibility in 150th anniversary year -

In celebrating its 150th anniversary year, Bacardi Limited highlights its long-standing legacy of philanthropy and community involvement with special focus on employees giving back through volunteerism. Through its “Spirit for Life, Caring Together” program, Bacardi celebrates its year-round corporate responsibility (CR) activities and declares the month of May for employees to work together on community projects around the world including home building and meal distribution for needy families; fundraisers for educational, arts and cultural programs; clothing and blood drives; young adult mentorship programs; park and community center clean-ups; recycling programs; bat conservation efforts; among others.

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/53407-bacardi-150-anniversary-celebrates-corporate-social-responsibility-enviro

(Photo: http://photos.prnewswire.com/prnh/20120516/MM06111 )

“Long before my great-great-grandfather founded the Bacardi company, he was a leader in giving back to his community. In 1852, he volunteered to be the organizer for relief aid after an earthquake devastated his hometown of Santiago de Cuba,” said Facundo L. Bacardi, Chairman of Bacardi Limited and a fifth generation Bacardi family member. “Both the Bacardi family and Company continue to carry on this commitment of responsibility and community service.”

The “Spirit for Life, Caring Together” initiative gives nearly 6,000 Bacardi employees in more than 75 locations around the world the opportunity to take time off from work to volunteer or support a cause through locally organized team activities. The program reinforces the Company’s purpose and values and demonstrates the Bacardi commitment to the environment and sustainable business practices, to communities where we craft and sell our products, and to consumers who enjoy them.

“Bacardi recognizes the importance of local communities and plays an active role in giving back by supporting our employees to make a difference to an organization in a team experience. Our actions in corporate social responsibility are guided by our core values of Trust, Passion, Caring and Excellence,” said Ed Shirley, President and Chief Executive of Bacardi Limited, the largest privately-held spirits company in the world. “By caring about the world around us, we create trust with our consumers. We aim to strengthen these bonds by acting responsibly in everything we do.”

Philanthropy and community involvement is one of the areas of focus for Bacardi Limited in Corporate Responsibility.

Other CR achievements include:

– Cut usage of natural resources to maximize reduction of its carbon footprint, waste and water usage
– Over the past five years, water consumption globally reduced by 50% and energy used cut by 29%
– Bacardi operations in the UK achieved Carbon Trust Standard certification
– Bacardi is the only major spirits company to be certified by the world’s most recognized standards for Quality, Environment, and Health and Safety ฤ the “Triple Crown” of ISO 9001, ISO 14001 and OHSAS 18001 ฤ for all its production facilities globally, putting the company among an elite group of the world’s best-run companies
– In 2011, five country-level operations were recognized in Great Place to Work(R) and other top employer rankings
– The award-winning “Champions Drink Responsibly” social responsibility campaign featuring Bacardi Limited Global Social Responsibility Ambassador and world tennis champion Rafael Nadal has engaged with more than 45 million consumers worldwide

As part of this monthlong dedication in our 150th year to employee volunteerism, these facts, and more, are showcased in a just-published brochure featuring “150 Corporate Responsibility Facts” from the five Bacardi Limited CR pillars of Marketplace; Environment, Health & Safety; Responsible Sourcing; People; and Philanthropy & Community Involvement.

“It is extremely generous of a company such as Bacardi to become so involved in the work we do here in Hampshire to help the homeless and to take so much of all your time out from work to assist us,” commented Michele Price with Winchester Nightshelter in the United Kingdom. “The impact Bacardi has had with providing basic needs of shelter, food, and hygiene to the homeless is truly tremendous. We would not be able to achieve anything on this scale without such help.”

Habitat for Humanity of Greater Miami CEO Mario Artecona added, “Bacardi sets the benchmark as to corporate responsibility. The proof is they are out there getting their hands dirty and helping put families in homes.” Nearly 40 Bacardi employees helped build three homes for local South Florida families in need.

To learn more about Corporate Responsibility best practices by the Company’s internationally-recognized brands, including BACARDI(R) Rum, MARTINI(R) Asti and DEWAR’S(R) Blended Scotch Whisky, visit the Bacardi Limited YouTube channel to watch videos about how the BACARDI facility in Puerto Rico utilizes wind power and turns trash into treasure with recycled promotional banners, DEWAR’S commitment to the Scottish environment, and sustainable business practices for MARTINI grape growing in Italy.

Download the Corporate Responsibility Report to learn more about Bacardi Limited Corporate Responsibility (CR) best practices. Or, to learn more about Bacardi and its pioneering heritage, visit the 150th anniversary section at www.BacardiLimited.com/150. Media can register to receive information on Bacardi 150th anniversary activities, as well as access multimedia assets at www.BacardiMediaCentre.com.

About Bacardi Limited
Bacardi Limited, the largest privately-held spirits company in the world, produces and markets internationally-recognized spirits and wines. Its brand portfolio comprises more than 200 brands and labels, including BACARDI(R) rum, the world’s best-selling and most-awarded rum; GREY GOOSE(R) vodka, the world’s leading super-premium vodka; DEWAR’S(R) Blended Scotch whisky, the top-selling blended Scotch whisky in the U.S.; BOMBAY SAPPHIRE(R) gin, the top-valued and fastest-growing premium gin in the world; MARTINI(R) vermouth and sparkling wines, the world’s leading vermouth; CAZADORES(R) 100% blue agave tequila, the number-one premium tequila in Mexico and a top-selling premium tequila in the United States; ERISTOFF(R) vodka, one of the fastest-growing vodka brands in the world; and other leading and emerging brands.

Founded in Santiago de Cuba on February 4, 1862, and family-owned for the past seven generations, Bacardi now employs nearly 6,000 people, manufactures its brands at 27 facilities in 16 markets on four continents, and sells in more than 150 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. www.BacardiLimited.com

CONTACT: Amy Federman, +1-441-294-1110, afederman@bacardi.com, Patricia M. Neal, +1-441-294-1110

New research presented at the European Society of Paediatric Infectious Diseases (ESPID) Annual Meeting in Thessaloniki, Greece shows that most parents (61%) surveyed as part of an international study of six countries are unaware that current vaccinations do not protect their children from all forms of meningitis.(1) The data from the survey of parents with infants under the age of two also show that only 16% of parents surveyed know that children under 12 months are at greatest risk of contracting the killer disease.(1)

Meningitis is a potentially deadly inflammation of the brain and spinal cord, which can be the result of a virus, bacteria, or other microorganisms, and can be associated with a potentially life-threatening blood infection (sepsis).(2,3) Each year hundreds of thousands of people around the world die from meningitis, or suffer life-long disabilities. Bacterial meningitis, which is the most severe and common form, causes around 170,000 deaths globally every year.(3,4) While the disease can affect people of all ages, infants, children and adolescents are at an increased risk of infection.(5)

Further results from the study showed that:(1)

– Fewer than 4 in 10 parents (900/2460) knew their child had already received a meningococcal vaccine.
– Parents in Australia, Canada, Spain and the UK were more likely to know if their child had been vaccinated against meningococcal disease, compared to parents in France, Germany and Sweden.
– Almost 50% of Swedish parents said they were unsure of their child’s meningococcal vaccine status.
– Compared with parents in other countries, parents in France and the UK were more likely to realise there were other types of meningitis not covered by current vaccines.
– After exposure to meningococcal B disease (MenB) information more parents (68% vs. 54% prior to seeing this information) predicted they would be highly likely to accept vaccination for their child (0-6 months of age) against MenB, if approved and recommended by their child’s healthcare provider.
– Parents in Australia, Spain, and the UK were the most likely to allow their child to receive MenB vaccination; French parents were relatively less likely.

Although great strides have been made over the last decade with the introduction of vaccines for some types of meningitis, there is currently no broadly-effective vaccine to protect against MenB.(6) Candidate vaccines for this type of meningitis are currently in development.

One of the Confederation of Meningitis Organisation’s (CoMO’s) founding members based in the UK, The Meningitis Trust, was involved in the study. Sue Davie, Chief Executive and co-author of the international survey, commented on the lack of awareness about vaccine protection against meningitis.

“This misunderstanding about meningitis vaccine protection suggests that the majority of parents do not consider meningitis when their child is ill, thinking they are protected. Sadly, this can cost lives or lead to a child facing a future changed forever with devastating after-effects,” Sue Davie said.

“We have to address this complacency as a matter of urgency and ensure meningitis remains at the forefront of parents’ minds while there are not vaccines available for all types of this disease.”

Commenting on the global significance of the data, Bruce Langoulant, President and Member of the Governing Council of CoMO and father of a meningitis survivor with significant disabilities said: “We are proud that one of our founding members, The Meningitis Trust, has been involved in such significant global research. It’s clear from the new data presented that there is potentially a worldwide lack of awareness that meningitis vaccines do not fully protect against all types of the disease – something that the global community needs to work on. In the absence of vaccines for all types of meningitis, it is critically important that parents know the signs and symptoms of meningitis and understand the urgency to treat the disease.”

To drive better awareness of the signs and symptoms of meningitis, CoMO recently launched a video entitled ‘If I’d known then what I know now’ that features a range of people affected by meningitis and shares their knowledge in an effort to educate others and reduce the incidence of those impacted by the disease. The video can be accessed at: http://www.youtube.com/user/COMOmeningitis/featured.

Notes to Editors

About the Survey

– 2,460 parents (with a child under two) and 725 healthcare professionals from across Europe, Canada and Australia were surveyed.
– The countries surveyed were Australia, France, Germany, Spain, Sweden, and the United Kingdom.
– The survey was conducted between 5 September and 1 November 2011.
– The survey was conducted by IPSOS Healthcare on behalf of Novartis Vaccines and Diagnostics, who sponsored the research.

About Meningitis
Meningitis is an inflammation of the brain and spinal cord, and can be the result of infection by bacteria, viruses and fungi.(2) Bacterial meningitis is the most serious type of meningitis, and it is often associated with a potentially life-threatening blood infection (sepsis).(2,3) The most common bacteria causing meningitis and septicaemia are Haemophilus influenzae type b (Hib), Streptococcus pneumoniae (pneumococcal) and Neisseria meningitidis (meningococcal).(3)

Meningitis can develop rapidly and its symptoms often resemble the flu (e.g., fever, drowsiness and headache), which makes it difficult for doctors to diagnose and patients/family members to recognise.(5) Even with early and appropriate treatment, the rates of death and serious long-term effects of the disease can be high.(2) Survivors often suffer serious long-term consequences, such as deafness, brain damage, and limb loss.(2,4) While the disease can affect people of all ages, infants, children and adolescents are at an increased risk of infection.(5) Immunisation against bacterial meningitis with those vaccines that are available is essential;(2) no one should suffer from this disease.

About the Confederation of Meningitis Organisations (CoMO)
CoMO was founded in September 2004, at the close of a World Conference of Meningitis Organisations. Encouraged by the information shared at the meeting, 20 delegates formed CoMO in order to help support the fight against meningitis by emphasising the global burden of the disease and supporting the establishment of new meningitis and children’s health organisations.

CoMO now has 34 members in 22 countries around the globe. The global organisation is focussed on stopping meningitis worldwide and supporting its member organisations in raising awareness about meningitis, growing its membership base to provide support to as many countries across the world as possible, and supporting those dealing with the potentially devastating consequences of this disease.

To learn more about CoMO and its member organisations, visit www.comoonline.org.

References
(1) Rodrigo C, Bakhache P, Rose M, et al. Parental awareness and knowledge about invasive meningococcal disease: results of a multinational survey. Poster presented at the 30th Annual Meeting of the European Society for Paediatric Infectious Diseases, 8-12 May 2012.
(2) WHO. Meningococcal meningitis. Fact sheet No141. December 2011. Available at: http://www.who.int/mediacentre/factsheets/fs141/en/index.html. Accessed March 2012
(3) CDC. Meningitis questions & answers. Available at: http://www.cdc.gov/meningococcal/about/index.html. Accessed March 2012.
(4) Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book: Course Textbook). 10th Edition, 2nd printing. February 2008 update. Available at: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/mening.pdf. Accessed March 2012.
(5) CDC. Factsheet: Meningococcal Disease and Meningococcal Vaccine. November 16, 2011. Available at: http://www.cdc.gov/vaccines/vpd-vac/mening/vac-mening-fs.htm. Accessed March 2012.
(6) Meningitis Trust factsheet. Meningitis vaccines: The facts. Available at: www.meningitis-trust.org/meningitis-info/what-is-meningitis/vaccines/. Accessed April 2012.

CONTACT: Georgia Ball of Marketing & Fundraising Officer of CoMO, +61 499 078 577, gball@ichr.uwa.au, or Jessica Langoulant, Marketing & Communications Officer, +61 8 9489 7789, +61 408 926 305, jlangoulant@ichr.uwa.au

Corporate sponsorship and marketing consulting group Boss Global Media has signed an exclusive partnership with International Sports Management (ISM) to handle sponsorships and endorsement representation for ISM’s client athletes. ISM is an international sports management agency that represents prominent international professional athletes focusing on golfers and cricketers. “ISM’s list of athletes is stellar,” says BGM VP for Business Development Hayden Trepeck. “We are excited about the opportunity to partner their high-profile clients with preeminent corporate sponsors.”

(Logo: http://photos.prnewswire.com/prnh/20120329/FL79011LOGO-b )

ISM was founded in 1989 by former professional golfer and current Managing Director Andrew “Chubby” Chandler to meet the management needs of European professional golfers and cricketers. ISM is currently expanding its clientele into professional footballers/soccer players, as well. ISM’s roster of high-profile clients includes major’s champions Darren Clarke, Louis Oosthuizen, and Charl Schwartzel, as well as former #1 player in the world Lee Westwood. ISM also manages several golf tournaments around the world. “I am delighted that Boss Global Media will be representing ISM clients and excited about the opportunities this partnership will generate,” said Chandler.

To inquire about partnership opportunities for any of ISM’s athletes please contact BGM VP for Business Development Hayden Trepeck at 1.561.289.7952 or HT@BossGlobalMedia.com

A Worldwide Leader in Athletic and Entertainment Sponsorship

Boss Global Media is a worldwide leader in athletic and entertainment sponsorship with clients around the world. BGM is committed to serving its athletes, corporations, organizations and businesses through sponsorship, media, and entertainment marketing services with the goal of increasing the bottom line for all of its clients. BGM’s representation has led to many mutually beneficial partnerships between high-profile individuals, organizations and corporations.

Boss Global Media
Hayden Trepeck
Phone US: 800-385-0524
HT@BossGlobalMedia.com
www.bossglobalmedia.com
@BossGlobalMedia